The Delta variant of coronavirus, a highly infectious form of the virus that was initially discovered in India in December, is now causing concern in the United States. Similar to earlier variations, the Delta variant has spread to a number of nations across the globe, most notably to the United Kingdom, where it is currently responsible for approximately 99 percent of all new cases.
The Effectiveness Of Vaccines Against The Delta Variant Is Shown Here
In March of this year, the United States stated that it had verified a COVID-19 case using the Delta form of the virus. It has already surpassed all other variants in terms of prevalence throughout the country, accounting for more than 98 percent of all new infections.
The number of COVID-19 cases is rapidly increasing in the United States once again. According to statistics from the Centers for Disease Control & Prevention, the average number of COVID-19 cases reported each day is more than 150,000 on average (CDC).
According to studies, this increase may be ascribed in part to the fact that the Delta variation is believed to be 60 percent more transmittable than the alpha form, resulting in an increase in transmission. According to recent research conducted by the Chinese Academy of Medical Sciences, “viral loads in Delta illnesses are [about] 1,000 times higher” than those produced by earlier SARS-CoV-2 versions. Furthermore, regions with low vaccine coverage have been shown to be more susceptible to an increase in illnesses.
Dr. Rochelle Walensky, Director of the Centers for Disease Control and Prevention, issued a warning about this possible increase earlier this month. According to her, she said at a press conference that early statistics indicated that 99.5 percent of the individuals who have died from COVID-19 in January were not vaccinated. During the month of July, confirmed coronavirus infections increased dramatically in Missouri, which had a vaccination rate of almost 43 percent.
According to the most recent data available, Vermont has one of the highest immunization rates of any state in the US, with an overall rate of 69 percent. This is consistent with results from a trial conducted in the United Kingdom, which showed that the Delta variation was twice as likely to result in hospitalization and that both the AstraZeneca-Oxford COVID-19 vaccination and the Pfizer-BioNTech COVID-19 vaccine were successful in decreasing this risk.
In New York, Dr. Theodore Strange, the interim head of medicine at the Staten Island University Hospital, said that the evidence supports his assertions. In all, more than 430 million dosages of COVID-19 vaccination have been given in the United States so far this year. Over 171 million individuals have got two doses of the vaccine.
That implies that more than 60% of the population of the United States over the age of 12 has received all of their vaccinations. There are presently three COVID-19 vaccines that were approved for use by the Food and Drug Administration (FDA) and are in widespread use across the United States.
With the FDA’s approval of the Pfizer-BioNTech vaccine, it became the first to obtain both full approval and emergency use authorization (EUA)Trusted Source. Individuals with weakened immune systems may also get the vaccination under the EUA if they are between the ages of 12 and 15.